Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners

Sundström J, Bodegard J, Bollmann A, et al. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: the CaReMe CKD study. Lancet Reg Health Eur. 2022;20:100438.

Article  PubMed  PubMed Central  Google Scholar 

Fraser SD, Blakeman T. Chronic kidney disease: identification and management in primary care. Pragmat Obs Res. 2016;7:21–32.

PubMed  PubMed Central  Google Scholar 

Chu CD, McCulloch CE, Banerjee T, et al. CKD awareness among US adults by future risk of kidney failure. Am J Kidney Dis. 2020;76(2):174–83.

Article  PubMed  PubMed Central  Google Scholar 

Tangri N, Moriyama T, Schneider MP, et al. Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open. 2023;13(5):e067386.

Article  PubMed  PubMed Central  Google Scholar 

Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs without type 2 diabetes. BMC Nephrol. 2020;21(1):167.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tangri N, Alvarez CS, Arnold M, Barone S, Cebrián A, Chen H, et al. Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: insights from REVEAL-CKD. Eur J Clin Invest. 2024. https://doi.org/10.1111/eci.14282.

Article  PubMed  Google Scholar 

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117–S314.

Tangri N, Peach EJ, Franzén S, Barone S, Kushner PR. Patient management and clinical outcomes associated with a recorded diagnosis of stage 3 chronic kidney disease: the REVEAL-CKD study. Adv Ther. 2023;40(6):2869–85.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020;16(5):251.

Article  PubMed  Google Scholar 

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.

Article  PubMed  Google Scholar 

Verberne WR, Das-Gupta Z, Allegretti AS, et al. Development of an international standard set of value-based outcome measures for patients with chronic kidney disease: a report of the International Consortium for Health Outcomes Measurement (ICHOM) CKD Working Group. Am J Kidney Dis. 2019;73(3):372–84.

Article  PubMed  Google Scholar 

Zoccali C, Mark PB, Sarafidis P, et al. Diagnosis of cardiovascular disease in patients with chronic kidney disease. Nat Rev Nephrol. 2023;19(11):733–46.

Article  PubMed  Google Scholar 

Szlagor M, Dybiec J, Młynarska E, Rysz J, Franczyk B. Chronic kidney disease as a comorbidity in heart failure. Int J Mol Sci. 2023;24(3):2988.

Article  PubMed  PubMed Central  CAS  Google Scholar 

MacRae C, Mercer SW, Guthrie B, Henderson D. Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care. Br J Gen Pract. 2021;71(704):e243–9.

Article  PubMed  PubMed Central  Google Scholar 

Chadban S, Esposito C, Rangaswami J, Wu M-S, Hull R, Elsayed H, et al. #4529 PACE-CKD: Financial burden and work productivity of patients with CKD and caregivers: results from a US survey. Nephrol Dial Transplant. 2023;38(Suppl 1):4529.

Google Scholar 

Esposito C, Chadban S, Rangaswami J, et al. #3990 PACE-CKD: Health-related quality of life of patients with CKD and caregivers: results from a US survey. Nephrol Dial Transplant. 2023;38(Suppl 1):3990.

Google Scholar 

Carrero J, Pollock C, Kanda E, et al. #3393 Patient-reported outcomes in early versus advanced chronic kidney disease: evidence from baseline data in the discover CKD prospective study. Nephrol Dial Transplant. 2023;38.

Tummalapalli SL, Powe NR, Keyhani S. Trends in quality of care for patients with CKD in the United States. Clin J Am Soc Nephrol. 2019;14(8):1142–50.

Article  PubMed  PubMed Central  Google Scholar 

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11.

Article  Google Scholar 

Jha V, Al-Ghamdi SMG, Li G, et al. Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the inside CKD research programme. Adv Ther. 2023;40(10):4405–20.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization: Reducing noncommunicable diseases: a signature roadmap for the WHO European Region. https://www.who.int/europe/publications/i/item/WHO-EURO-2022-6620-46386-67147. Accessed July 2023.

ISN Global Kidney Health Atlas. https://www.theisn.org/initiatives/global-kidney-health-atlas/. Accessed 2023.

Francis A, Harhay MN, Ong ACM, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473.

Article  PubMed  Google Scholar 

Khunti K, Sathanapally H, Mountain P. Multiple long term conditions, multimorbidity, and co-morbidities: we should reconsider the terminology we use. BMJ. 2023;383:2327.

Article  PubMed  Google Scholar 

Nee R, Yuan CM, Narva AS, Yan G, Norris KC. Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease. Nephrol Dial Transplant. 2023;38(3):532–41.

Article  PubMed  Google Scholar 

Sperati CJ, Soman S, Agrawal V, et al. Primary care physicians’ perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study. PLoS ONE. 2019;14(8):e0221325.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Khunti K, Jabbour S, Cos X, et al. Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: barriers and solutions for improving uptake in routine clinical practice. Diabetes Obes Metab. 2022;24(7):1187–96.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022;79(2):268–88.e1.

Article  PubMed  Google Scholar 

Madero M, Chertow GM, Mark PB. SGLT2 inhibitor use in chronic kidney disease: supporting cardiovascular, kidney, and metabolic health. Kidney Med. 2024;6(8):100851.

Article  Google Scholar 

Heerspink HJL, Jongs N, Chertow GM, et al. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9(11):743–54.

Article  PubMed  CAS  Google Scholar 

Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63(5):789–97.

Article  PubMed  Google Scholar 

Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD. Population-wide screening for chronic kidney disease: a cost-effectiveness analysis. Ann Intern Med. 2023;176(6):788–97.

Article  PubMed  PubMed Central  Google Scholar 

Mancia G, Kreutz R, Brunström M, et al. ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hyperten. 2023. https://doi.org/10.1097/HJH.0000000000003480.

Article  Google Scholar 

Mark PB, Sarafidis P, Ekart R, et al. SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA. Nephrol Dial Transplant. 2023;38(11):2444–55.

Schroeder EB, Yang X, Thorp ML, et al. Predicting 5-year risk of RRT in stage 3 or 4 CKD: development and external validation. Clin J Am Soc Nephrol. 2017;12(1):87–94.

Article  PubMed  CAS  Google Scholar 

Grams ME, Brunskill NJ, Ballew SH, et al. The kidney failure risk equation: evaluation of novel input variables including eGFR estimated using the CKD-EPI 2021 equation in 59 cohorts. J Am Soc Nephrol. 2023;34(3):482–94.

Article  PubMed  PubMed Central  Google Scholar 

Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. The kidney failure risk equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 2019;16(11):e1002955.

Comments (0)

No login
gif